Basaglar 100 Unit

BASAGLAR 100 Unit is a long-acting insulin glargine solution for subcutaneous use, designed to help manage blood sugar levels in diabetes care. This medication is manufactured by Eli Lilly Canada Inc. and is suitable for daily administration.

BASAGLAR 100 Unit is primarily used for the management of diabetes, helping to control blood sugar levels over a prolonged period. It is often prescribed as part of a comprehensive diabetes treatment plan, which may include diet and exercise. This insulin glargine solution is intended for subcutaneous injection, typically once a day, to provide consistent insulin coverage throughout the day and night.

Common effects of BASAGLAR 100 Unit may include mild to moderate reactions at the injection site, such as redness, swelling, or itching. Some users may experience hypoglycemia, characterized by symptoms like sweating, dizziness, or confusion. It is important to monitor blood sugar levels regularly while using this medication to ensure it is working effectively.

BASAGLAR 100 Unit should be stored properly to maintain its effectiveness. Keep it refrigerated and protect it from light and heat. Always check the solution for particles or discoloration before use. If you notice any changes, do not use the medication. It is also important to follow the administration instructions provided by your healthcare professional to ensure safe and effective use.

BASAGLAR 100 Unit may interact with other medications, including oral hypoglycemic agents, corticosteroids, and certain antidepressants. Alcohol consumption can also affect blood sugar levels and should be monitored carefully. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.